Where in China can Trientine capsules be sold?

Trientine(Trientine) is a prescription drug mainly used to treat Wilson’s Disease (Wilson’s Disease, also known as hepatolenticular degeneration; rare disease). It is a chelating drug that forms a soluble complex by combining with excess copper ions in the body, thereby promoting the excretion of copper and reducing the deposition of copper in the liver, brain and other tissues. Currently in China, although the original drug trientine has been marketed through specific import channels, it has not yet been widely circulated across the country. If patients need to purchase, they can usually only apply and purchase through designated imported pharmacies, specially approved pharmacies in some tertiary hospitals, or cross-border medical channels.

According to domestic drug registration information, trientine has not yet been included in the regular supply catalog of the Chinese Pharmacopoeia, which means that it is difficult to purchase it directly in ordinary pharmacies or e-commerce platforms. Some hospitals with special approval qualifications for imported drugs may provide dispensing channels for a small amount of imported drugs for patients with Wilson's disease, but patients are required to provide clear diagnostic reports and doctor's prescriptions. Under this model, hospitals usually decide whether to use trientine treatment based on the patient's condition and copper metabolism monitoring results.

In terms of price, since trientine is an imported specialty drug, its cost is relatively high. The German version of the original drugTrientine (trade name: Syprine or Cufence) in overseas markets, the common specification is 200mg × 100 tablets, and the price per box may exceed 40,000 yuan, and the price will fluctuate with the exchange rate and logistics costs. Some pharmaceutical companies (such as Yin Yin) have produced generic versions of trientine capsules. The active ingredients are the same as the original drug, but the price is relatively low. Currently, the price information in the international market is not stable. For domestic patients, relevant drugs can be obtained through overseas pharmacy platforms or cross-border medical institutions, but it is recommended that they be purchased through formal channels to avoid the risk of counterfeit drugs or substandard generic drugs.

Reference materials:https://www.cufence.com/